Drawing for TOMOWA

USPTO serial 79165000

TOMOWA

Reviewed by CopyMark Law Group

Reg. 4924788Status 404
Filing date
Status date
Registration date
Mar 29, 2016
Examiner
WILKE, JOHN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TOMOWA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kaushal Odedra

Kaushal Odedra ODEDRA LAW OFFICE, PLLC2020 Pennsylvania Ave, NW #152Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Industrial chemicals; chemicals for use in the manufacture of dietary supplements and foods; chemical additives for use in the manufacture of dietary supplements and foods; amino acids for use in the manufacture of dietary supplements and foods; bacteriological culture mediums other than for medical or veterinary purposes; cell culture mediums other than for medical or veterinary purposes; cell culture mediums for research and for scientific purposes, other than for medical or veterinary purposes; plant growth regulating preparations; artificial sweeteners chemical preparationsSECTION 71 - CANCELLED—
005Pharmaceuticals, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceuticals for the supportive care in the treatment of cancer or malignant tumors, pharmaceuticals for the treatment of cancer or malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, endocrine diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; pharmaceutical preparations, namely, diagnostic preparations for medical purposes, chemical reagents for medical or veterinary purposes, diagnostic reagents for medical use and vitamin preparations, pharmaceutical preparations for the supportive care in the treatment of cancer or malignant tumors, pharmaceutical preparations for the treatment of cancer or malignant tumors, pain, hematological disorders, renal diseases, endocrine diseases, immunity disorders, neurological, psychiatric and other central nervous system disorders, infectious diseases, parasitic diseases, endocrine diseases, nutritional diseases, metabolic diseases, congenital malformations, traumatic injury, eye diseases, ear diseases, circulatory system diseases, diseases of the respiratory system, digestive system diseases, skin diseases, diseases of the musculoskeletal system and diseases of the genitourinary system; cells for medical purposes; bacteriological culture mediums for medical and veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells, and for use in production of active ingredients of pharmaceuticals; cell culture mediums for medical and veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells, and for use in production of active ingredients of pharmaceuticals; cell culture mediums for research and for scientific purposes only for medical or veterinary purposes for use in augmentation, differentiation or cultivation of bone, tissue and cells, and for use in production of active ingredients of pharmaceuticals; reagent paper for medical purposes; gauze for dressings; empty capsules for pharmaceuticals; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; lacteal flour for babies; dietary supplements; dietetic beverages, namely, juice drinks, jelly drinks and milk adapted for medical purposes; dietetic foods, namely, crackers, candy, jelly, granule and swallowing assisting food adapted for medical purposes; beverages for babies adapted for medical purposes; food for babies; dietary supplements for animalsSECTION 71 - CANCELLED—
010Apparatus for use in medical analysis, namely, apparatus for analysis of biological materials for medical purposes, apparatus for analysis of chemicals for medical purposes, apparatus for analysis of drugs, apparatus for analysis of drug metabolites, medical diagnostic instruments for the analysis of body fluids; medical apparatus, namely, injection device for pharmaceuticals, injection needles for medical purposes, inhalation device for pharmaceuticals, defibrillators, medical apparatus for treating respiratory conditions, infusion devise for administering drugs, infusion pumps for delivering measured amounts of solutions into the bloodstream over time, blood transfusion apparatus, blood component separation apparatus for medical purposes, diagnostic apparatus for detecting cancer, diagnostic apparatus for detecting infection, diagnostic apparatus for detecting the disease state of human illnesses, containers and trays specially designed for transporting and holding pharmaceuticals, high frequency electromagnetic therapy apparatus, low frequency electric therapy apparatus, short wave therapy machines and apparatus, static electric therapy apparatus, ultraviolet radiator units for therapeutic purposes, infrared radiator units for therapeutic purposes, mercury arc lamp units for therapeutic purposes, carbon arc lamp units for therapeutic purposes, massage apparatus for medical purposes; medical instruments, namely, for use in injection for administering drugs, infusion for administering drugs, inhalation for administering drugs, transfusion, separation of blood component for medical purposes, diagnosis for detecting cancer, diagnosis for detecting infection, diagnosis for detecting the disease state of human illnesses, transporting and holding pharmaceuticals, analysis of biological materials for medical purposes, analysis of chemicals for medical purposes, analysis of drugs, analysis of drug metabolites, analysis of body fluids; surgical apparatus, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; surgical instruments, namely, for use in open heart surgery for monitoring oxygen gas analysis and vital sign, open abdominal surgery for monitoring oxygen gas analysis and vital sign, open chest surgery for monitoring oxygen gas analysis and vital sign; gloves for medical purposes; sanitary masks for medical purposesSECTION 71 - CANCELLED—
040Custom manufacture of pharmaceuticals; extraction, production and synthesis of pharmaceuticals for others; custom manufacture of industrial chemicals; custom manufacture of medical apparatus and medical instruments; manufacture of antibody-producing cells for othersSECTION 71 - CANCELLED—
042Pharmaceutical research; research of chemicals; analysis of chemicals; testing, inspection or research of pharmaceuticals; testing, inspection or research of chemicals; testing, inspection or research of cosmetics; testing, inspection or research of foodstuff; providing technical advice relating to chemical research; providing technical advice relating to pharmaceutical development; providing technical advice relating to chemical development; rental of laboratory apparatus; rental of laboratory instrumentsSECTION 71 - CANCELLED—
044Providing medical information; medical examinations; preparation and dispensing of medication; dietary and nutritional guidance; veterinary services; rental of medical apparatus; rental of medical instrumentsSECTION 71 - CANCELLED—
045Licensing of technology in the field of pharmaceuticals, medicine and chemicals; patent licensing; licensing of intellectual property; providing information about exploitation and licensing of intellectual property rightsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 13, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 22, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 21, 2023INPCINVALIDATION PROCESSED—
Jun 14, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 14, 2022C71TCANCELLED SECTION 71—
Jul 22, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 1, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 1, 2016FIMPFINAL DISPOSITION PROCESSED—
Jun 29, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 29, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 15, 2016GPNXNOTIFICATION PROCESSED BY IB—
Jan 12, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 28, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2015NPUBNOTICE OF PUBLICATION—
Dec 23, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 7, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 24, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 23, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 23, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2015ALIEASSIGNED TO LIE—
Nov 1, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2015RFNTREFUSAL PROCESSED BY IB—
May 20, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 20, 2015RFRRREFUSAL PROCESSED BY MPU—
May 19, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 19, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 18, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 16, 2015DOCKASSIGNED TO EXAMINER—
May 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance